Posts about:
I recently led a team of researchers in a large-scale observational study, which was accepted and published by The Lancet Psychiatry. To our knowledge, our study was the first to study the impact of early clinical trajectory across multiple psychiatric diagnoses.
Our mission is to build the world’s richest real-world evidence platform for behavioral health to transform clinical research and care delivery. Our NeuroBlu Database delivers value to our customers by providing meaningful clinical information that helps to produce evidence that could not be easily generated otherwise.
This year at the American Society of Clinical Psychopharmacology’s annual conference, I had the privilege to organize and chair a panel discussion on challenges and opportunities in leveraging real-world evidence to inform the development of new treatments in behavioral health.
